sur CureVac (NASDAQ:CVAC)
CureVac Announces Upcoming Financial Results and Business Update
CureVac N.V., a biopharmaceutical company specializing in messenger RNA (mRNA) technology, is set to release its financial results for the third quarter and the first nine months of 2024. The announcement is scheduled for November 12, 2024. CureVac will provide a detailed business update along with the financial results during a conference call and webcast on the same day at 3 p.m. CET / 9 a.m. EST. Interested parties can join the conference call through various dial-in options or access the live webcast via CureVac's official website.
The company is recognized for its advancements in mRNA technology, contributing to the development of vaccines and therapeutic proteins. CureVac's initiatives extend to cancer vaccines and other novel therapeutic areas. The upcoming financial report and business update will provide insights into the company’s strategies and market positions during 2024.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de CureVac